In a study by Kontani et al., primary breast tumor samples were analyzed, showing that 70% of cases exhibited minimal destruction by the patient’s own CTLs, which was directly linked to decreased or altered expression of the mucin-1 (MUC1; encoded by MUC1) antigen. This evidence concerns the gene MUC1 and breast neoplasm.